TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the Aegis Virtual Conference on May 7, 2024 at 9:00 am ET. Dr. Mor's presentation will be webcast live. The registration link to access the live presentation is included below and is also available at the Events section of the Chemomab website.
Chemomab Presentation at 2024 Aegis Virtual Conference
Date: | May 7, 2024 |